Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10813921 Method to predict response to pharmacological chaperone treatment of diseases

Patent 10813921 was granted and assigned to Amicus Therapeutics on October, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Amicus Therapeutics

Current Assignee

Amicus Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108139210

Date of Patent

October 27, 2020

Patent Application Number

160462470

Date Filed

July 26, 2018

Patent Citations Received

‌

US Patent 12109205 Methods of treating Fabry patients having renal impairment

‌

US Patent 11458128 Methods of treating Fabry patients having renal impairment

‌

US Patent 11241422 Methods for treatment of Fabry disease

‌

US Patent RE48608 Method to predict response to pharmacological chaperone treatment of diseases

‌

US Patent 11623916 Highly purified batches of pharmaceutical grade migalastat and methods of producing the same

‌

US Patent 11622962 Methods of treating Fabry patients having renal impairment

...

Patent Primary Examiner

‌

Karem Cochrane Carlson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10813921 Method to predict response to pharmacological chaperone treatment of diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API